Change in PSA velocity is a predictor of overall survival in men with biochemically-recurrent prostate cancer treated with non-hormonal agents: Combined analysis of four phase-2 trials

BACKGROUND: Multiple phase-2 trials in men with biochemically-recurrent prostate cancer (BRPC) have assessed the impact of non-hormonal agents on PSA kinetics. We have previously demonstrated that changes in PSA kinetics correlate with metastasis-free survival; however, it is unknown whether these c...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzman, Daniel L., Zhou, Xian C., Zahurak, Marianna L., Lin, Jianqing, Antonarakis, Emmanuel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323734/
https://www.ncbi.nlm.nih.gov/pubmed/25384338
http://dx.doi.org/10.1038/pcan.2014.44

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323734/
https://www.ncbi.nlm.nih.gov/pubmed/25384338
http://dx.doi.org/10.1038/pcan.2014.44

Ejemplares similares